F · Healthcare

SKINBIO THERAP LS-01 (5KW)

Biotechnology

SKINBIO THERAP LS-01 (5KW) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 5KW

P/E ratio

25.00

SKINBIO THERAP LS-01 (5KW) — FAQ

What is 5KW's P/E ratio?

The price-to-earnings (P/E) ratio for SKINBIO THERAP LS-01 (5KW) is 25.00 (data as of 2026-05-23).

Does SKINBIO THERAP LS-01 pay a dividend?

Dividend yield is not available in the current snapshot for SKINBIO THERAP LS-01 (5KW). Check the MyAverix Finance app for the latest dividend data.

What sector is SKINBIO THERAP LS-01 in?

SKINBIO THERAP LS-01 (5KW) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 5KW listed on?

5KW is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)